{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:03:02Z","timestamp":1784775782553,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Cancer Institute","award":["F99CA294262"],"award-info":[{"award-number":["F99CA294262"]}]},{"name":"National Cancer Institute","award":["U01CA292741"],"award-info":[{"award-number":["U01CA292741"]}]},{"DOI":"10.13039\/100001299","name":"Prevent Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001299","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-026-00772-5","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:27:16Z","timestamp":1782221236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Point-of-care hrHPV mRNA detection with reverse transcription recombinase polymerase amplification on a portable fluorimeter from provider-collected cervical samples in Maputo, Mozambique"],"prefix":"10.1186","volume":"21","author":[{"given":"Emilie Newsham","family":"Novak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cannon J.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoha","family":"Wazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Carns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Atif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane R.","family":"Montealegre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Scheurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesaltina","family":"Lorenzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila P.","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Schmeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2347-9467","authenticated-orcid":false,"given":"Rebecca R.","family":"Richards-Kortum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"772_CR1","unstructured":"Mozambique: Human papillomavirus and related cancers, fact sheet 2023. ICOIARC Inf Cent HPV Cancer; 2023."},{"issue":"4","key":"772_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/CEJ.0000000000000459","volume":"28","author":"M Brand\u00e3o","year":"2019","unstructured":"Brand\u00e3o M, Tulsid\u00e1s S, Damasceno A, Silva-Matos C, Carrilho C, Lunet N. Cervical cancer screening uptake in women aged between 15 and 64 years in Mozambique. Eur J Cancer Prev. 2019;28(4):338. https:\/\/doi.org\/10.1097\/CEJ.0000000000000459.","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"772_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13027-025-00655-1","volume":"20","author":"CM de Oliveira","year":"2025","unstructured":"de Oliveira CM, Rangeiro R, Osman N, Baker E, Neves A, Mariano AAN, et al. Evaluation of hpv risk groups among women enrolled in the mulher cervical cancer screening study in Mozambique. Infect Agent Cancer. 2025;20(1):24. https:\/\/doi.org\/10.1186\/s13027-025-00655-1. PubMed PMID: 40223080; PubMed Central PMCID: PMC11995624.","journal-title":"Infect Agent Cancer"},{"key":"772_CR4","unstructured":"National survey on the impact of HIV and AIDS (INSIDA) Mozambique: population-based HIV impact assessment [Internet]. Mozambique National Institute of Health. 2021. Available from: https:\/\/phia.icap.columbia.edu\/mozambique-summary-sheet-en-pt-2021\/#:~:text=The%20Mozambique%20Population%2DBased%20HIV,national%20and%20provincial%20HIV%20response"},{"key":"772_CR5","unstructured":"New recommendations for. screening and treatment to prevent cervical cancer [Internet]. [cited 2025 Sep 22]. Available from: https:\/\/www.who.int\/news\/item\/06-07-2021-new-recommendations-for-screening-and-treatment-to-prevent-cervical-cancer."},{"issue":"1","key":"772_CR6","doi-asserted-by":"publisher","first-page":"e065074","DOI":"10.1136\/bmjopen-2022-065074","volume":"13","author":"J Joseph","year":"2023","unstructured":"Joseph J, Demke O, Ameyan L, Bitilinyu-Bango J, Bourgoin B, Diop M, et al. Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries. BMJ Open. 2023;13(1):e065074. https:\/\/doi.org\/10.1136\/bmjopen-2022-065074.","journal-title":"BMJ Open"},{"key":"772_CR7","doi-asserted-by":"publisher","unstructured":"De Oliveira CM, Salcedo MMP, Monteiro E, Mariano A, Verdinho MJC, Juli\u00e3o RDAM, et al. HPV testing for cervical cancer screening in Mozambique: challenges and recommendations. J Glob Health Rep. 2022;6. https:\/\/doi.org\/10.29392\/001c.32432.","DOI":"10.29392\/001c.32432"},{"key":"772_CR8","unstructured":"Screening and treatment of precancerous lesions for secondary prevention of cervical cancer [Internet]. Unitaid \u2014 Global Health Campus. 2024. Available from: https:\/\/unitaid.org\/uploads\/Screening-and-treatment-of-precancerous-lesions-for-secondary-prevention-of-cervical-cancer-technology-landscape-report.pdf."},{"key":"772_CR9","unstructured":"Target product profiles for. human papillomavirus screening tests to detect cervical pre-cancer and cancer [Internet]. [cited 2025 Mar 15]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240100275."},{"issue":"1","key":"772_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ygyno.2010.09.013","volume":"120","author":"G Coquillard","year":"2011","unstructured":"Coquillard G, Palao B, Patterson BK. Quantification of intracellular HPV E6\/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol. 2011;120(1):89\u201393. https:\/\/doi.org\/10.1016\/j.ygyno.2010.09.013.","journal-title":"Gynecol Oncol"},{"issue":"9590","key":"772_CR11","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890\u2013907. https:\/\/doi.org\/10.1016\/S0140-6736(07)61416-0. PubMed PMID: 17826171.","journal-title":"Lancet"},{"issue":"3","key":"772_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","volume":"11","author":"G Ronco","year":"2010","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Palma PD, Mistro AD, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010;11(3):249\u201357. 2045(09)70360-2 PubMed PMID: 20089449.","journal-title":"Lancet Oncol"},{"key":"772_CR13","doi-asserted-by":"publisher","unstructured":"Pal A, Kundu R, Human papillomavirus E. and E7: the cervical cancer hallmarks and targets for therapy. Front Microbiol [Internet]. 2020 [cited 2022 Jun 1];10. Available from: https:\/\/www.frontiersin.org\/article\/; https:\/\/doi.org\/10.3389\/fmicb.2019.03116.","DOI":"10.3389\/fmicb.2019.03116"},{"issue":"9","key":"772_CR14","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1158\/1078-0432.CCR-06-2881","volume":"13","author":"PE Castle","year":"2007","unstructured":"Castle PE, Dockter J, Giachetti C, Garcia FAR, McCormick MK, Mitchell AL, et al. A Cross-sectional Study of a Prototype Carcinogenic Human Papillomavirus E6\/E7 Messenger RNA Assay for Detection of Cervical Precancer and Cancer. Clin Cancer Res. 2007;13(9):2599\u2013605. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2881.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"772_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13027-020-0278-x","volume":"15","author":"A Derbie","year":"2020","unstructured":"Derbie A, Mekonnen D, Woldeamanuel Y, Van Ostade X, Abebe T. HPV E6\/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review. Infect Agent Cancer. 2020;15(1):9. https:\/\/doi.org\/10.1186\/s13027-020-0278-x.","journal-title":"Infect Agent Cancer"},{"issue":"7","key":"772_CR16","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/S1470-2045(22)00294-7","volume":"23","author":"M Arbyn","year":"2022","unstructured":"Arbyn M, Simon M, de Sanjos\u00e9 S, Clarke MA, Poljak M, Rezhake R, et al. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis. Lancet Oncol. 2022;23(7):950\u201360. 2045(22)00294-7 PubMed PMID: 35709810.","journal-title":"Lancet Oncol"},{"key":"772_CR17","doi-asserted-by":"publisher","first-page":"6935030","DOI":"10.1155\/2019\/6935030","volume":"2019","author":"ACL Macedo","year":"2019","unstructured":"Macedo ACL, Gon\u00e7alves JCN, Bavaresco DV, Grande AJ, Chiaramonte Silva N, Rosa MI. Accuracy of mRNA HPV Tests for Triage of Precursor Lesions and Cervical Cancer: A Systematic Review and Meta-Analysis. J Oncol. 2019;2019:6935030. https:\/\/doi.org\/10.1155\/2019\/6935030. PubMed PMID: 31281360; PubMed Central PMCID: PMC6594270.","journal-title":"J Oncol"},{"issue":"15","key":"772_CR18","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.3390\/ijms26157450","volume":"26","author":"VV Nkwinika","year":"2025","unstructured":"Nkwinika VV, Amissah KA, Rakgole JN, Khaba MC, Magwira CA, Lebelo RL. APTIMA mRNA vs. DNA-Based HPV Assays: Analytical Performance Insights from a Resource-Limited South African Setting. Int J Mol Sci. 2025;26(15):7450. https:\/\/doi.org\/10.3390\/ijms26157450.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"772_CR19","doi-asserted-by":"publisher","first-page":"30450","DOI":"10.1038\/s41598-025-13583-2","volume":"15","author":"EN Novak","year":"2025","unstructured":"Novak EN, Ma A, Kundrod KA, Chang MM, Hansen CJ, Montealegre JR, et al. Extraction-free RT-RPA assay for detection of HPV16, HPV18, and HPV45 mRNA expression. Sci Rep. 2025;15(1):30450. https:\/\/doi.org\/10.1038\/s41598-025-13583-2.","journal-title":"Sci Rep"},{"key":"772_CR20","doi-asserted-by":"publisher","unstructured":"H\u00f6hn AK, Brambs CE, Hiller GGR, May D, Schmoeckel E, Horn LC, WHO classification of female genital tumors. 2020. Geburtshilfe Frauenheilkd. 2021;81(10):1145\u201353. https:\/\/doi.org\/10.1055\/a-1545-4279 PubMed PMID: 34629493; PubMed Central PMCID: PMC8494521.","DOI":"10.1055\/a-1545-4279"},{"issue":"11","key":"772_CR21","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356. 2045(10)70230-8 PubMed PMID: 20952254.","journal-title":"Lancet Oncol"},{"issue":"8","key":"772_CR22","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1128\/JCM.00382-10","volume":"48","author":"S Ratnam","year":"2010","unstructured":"Ratnam S, Coutlee F, Fontaine D, Bentley J, Escott N, Ghatage P, et al. Clinical Performance of the PreTect HPV-Proofer E6\/E7 mRNA Assay in Comparison with That of the Hybrid Capture 2 Test for Identification of Women at Risk of Cervical Cancer. J Clin Microbiol. 2010;48(8):2779\u201385. https:\/\/doi.org\/10.1128\/JCM.00382-10.","journal-title":"J Clin Microbiol"},{"key":"772_CR23","doi-asserted-by":"publisher","unstructured":"Dockter J, Schroder A, Hill C, Guzenski L, Monsonego J, Giachetti C. Clinical performance of the APTIMA\u00ae HPV Assay for the detection of high-risk HPV and high-grade cervical lesions. J Clin Virol. 2009; Update on Molecular Diagnostics for the Detection of Human Papillomavirus 45(S55\u201361). https:\/\/doi.org\/10.1016\/S1386-6532(09)70009-5.","DOI":"10.1016\/S1386-6532(09)70009-5"},{"issue":"22","key":"772_CR24","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.3390\/cancers15225453","volume":"15","author":"SW S\u00f8rbye","year":"2023","unstructured":"S\u00f8rbye SW, Falang BM, Botha MH, Snyman LC, van der Merwe H, Visser C, et al. Enhancing Cervical Cancer Prevention in South African Women: Primary HPV mRNA Screening with Different Genotype Combinations. Cancers. 2023;15(22):5453. https:\/\/doi.org\/10.3390\/cancers15225453.","journal-title":"Cancers"},{"issue":"7","key":"772_CR25","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/OLQ.0000000000001167","volume":"47","author":"JY Islam","year":"2020","unstructured":"Islam JY, Mutua MM, Kabare E, Manguro G, Hudgens MG, Poole C, et al. High-risk Human Papillomavirus Messenger RNA Testing in Wet and Dry Self-collected Specimens for High-grade Cervical Lesion Detection in Mombasa, Kenya. Sex Transm Dis. 2020;47(7):464. https:\/\/doi.org\/10.1097\/OLQ.0000000000001167.","journal-title":"Sex Transm Dis"},{"issue":"9","key":"772_CR26","doi-asserted-by":"publisher","first-page":"e0137299","DOI":"10.1371\/journal.pone.0137299","volume":"10","author":"PC Adamson","year":"2015","unstructured":"Adamson PC, Huchko MJ, Moss AM, Kinkel HF, Medina-Marino A. Acceptability and Accuracy of Cervical Cancer Screening Using a Self-Collected Tampon for HPV Messenger-RNA Testing among HIV-Infected Women in South Africa. PLoS ONE. 2015;10(9):e0137299. https:\/\/doi.org\/10.1371\/journal.pone.0137299.","journal-title":"PLoS ONE"},{"issue":"1","key":"772_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13027-019-0230-0","volume":"14","author":"M Nakalembe","year":"2019","unstructured":"Nakalembe M, Makanga P, Mubiru F, Swanson M, Martin J, Huchko M. Prevalence, correlates, and predictive value of high-risk human papillomavirus mRNA detection in a community-based cervical cancer screening program in western Uganda. Infect Agent Cancer. 2019;14(1):14. https:\/\/doi.org\/10.1186\/s13027-019-0230-0.","journal-title":"Infect Agent Cancer"},{"issue":"9","key":"772_CR28","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/cid\/cix135","volume":"64","author":"GM Clifford","year":"2017","unstructured":"Clifford GM, Tully S, Franceschi S. Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis. 2017;64(9):1228\u201335. https:\/\/doi.org\/10.1093\/cid\/cix135.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"772_CR29","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/S2214-109X","volume":"9","author":"D Stelzle","year":"2021","unstructured":"Stelzle D, Tanaka LF, Lee KK, Khalil AI, Baussano I, Shah ASV, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021;9(2):e161\u20139. https:\/\/doi.org\/10.1016\/S2214-109X. (20)30459-9 PubMed PMID: 33212031.","journal-title":"Lancet Glob Health"},{"key":"772_CR30","unstructured":"Recommendations on HPV mRNA testing. In: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: Use of mRNA tests for human papillomavirus (HPV) [Internet]. 2nd edition [Internet]. World Health Organization. 2021 [cited 2023 Dec 7]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK576611\/."},{"issue":"4","key":"772_CR31","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1021\/acs.analchem.5c05443","volume":"98","author":"KN Shimazu","year":"2026","unstructured":"Shimazu KN, Bender AT, Martin C, Gummalla N, Posner JD. Extraction-Free Scalable Sample Preparation for the Rapid Detection of HIV in Blood Plasma. Anal Chem. 2026;98(4):2797\u2013806. https:\/\/doi.org\/10.1021\/acs.analchem.5c05443.","journal-title":"Anal Chem"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-026-00772-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00772-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00772-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:56:01Z","timestamp":1784775361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13027-026-00772-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1186\/s13027-026-00772-5","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"25 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Participants provided written informed consent. The study was approved by the institutional review boards (IRBs) at Rice University, MD Anderson Cancer Center, Baylor College of Medicine, and the Committee for Bioethics in Health of Mozambique. This study was carried out in accordance with the Belmont Report and the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"52"}}